Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Our volunteers generously give us their time, skills and experience to tell people about our work, and to help us raise vital funds for research into better treatments and ultimately a cure for T1D.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Knowledge & support > Resource hub > Type 1 diabetes in older adults: A researcher’s perspective
Managing blood glucose in older adults with type 1 diabetes can be particularly challenging. Hypoglycaemia continues to be a risk of insulin therapy, which in older people can lead to serious consequences such as falls, fractures, and hospital admissions. To counter this, relaxed glucose targets are often suggested, but relaxing glucose targets too much can be dangerous, as it may increase the risk of complications like diabetic ketoacidosis.
Given these complexities, there is a clear need for specific guidelines to support the safe and effective management of type 1 diabetes in older adults.
The research idea came from meeting older adults with type 1 diabetes throughout my career. I saw that the complexities of type 1 diabetes management through the challenges of ageing led to an increase in care needs compared to people without diabetes, or even those with type 2 diabetes. I saw this as unjust, but when exploring the available research on the topic, I found limited evidence, and what was there was largely guided by research into ageing with type 2 diabetes. This motivated me to explore the topic in further depth.
My research uses different methods to assess the experiences of living with type 1 diabetes as an older person. Continuous glucose monitors were used to assess glucose levels in older adults living with varying degrees of frailty. Interviews with older adults were then conducted to understand more about their experience.
The results are not yet published but highlight the resilience of this group and the impact of advancements in diabetes technology over the last 50 years. They also highlight concerns about future care options for people living with type 1 diabetes.
People with type 1 diabetes often become experts in self-managing their diabetes, sometimes over several decades. Handing over diabetes management to a carer can be scary but is sometimes required, particularly where memory starts to be lost. Especially as insulin errors can be particularly dangerous.
With more people ageing with type 1 diabetes, it is likely that more will require such care. Services will need to adapt to meet the needs of people with type 1 diabetes who become unable to self-manage. This might involve bespoke education courses for carers, changes to the structure of district nurse provision, and greater awareness of type 1 diabetes within care homes.
The report Facing the Future by Breakthrough T1D highlights a need for change in the provision of type 1 diabetes care in older adults. Further research could hold some of the answers, in particular there are opportunities to consider how automated insulin delivery, or hybrid closed loop therapy could be adapted to this setting to make insulin administration safe in a person who has lost the ability to self-manage. Overall, keeping the person living with type 1 diabetes at the centre of considerations is key to true meaningful change in this group.
Download our report exploring the needs of people over the age of 45 living with T1D.
Crohn’s & Colitis UK is the newest member of our innovative, cross-disciplinary autoimmune research initiative, Connect Immune Research.
When menopause symptoms appeared, Sally Walker, 51, had already spent most of her life managing type 1 diabetes.
The National Axial Spondyloarthritis Society (NASS) is the newest member of our innovative autoimmune research initiative, Connect Immune Research.
I was diagnosed with type 1 diabetes in 1970, when I was 27. I became very unwell and weak; I wasn’t particularly thirsty, which is the first thing everybody assumes. I felt similar to when I had had glandular fever in 1965.
Our research is improving the lives of people with type 1 and making strides towards a cure. We’ll keep pushing until we make type 1 diabetes a thing of the past.
